Alzheimer’s disease: insights from genetic mouse models and current advances in human IPSC-derived neurons

Anne E. Harasta*, Lars M. Ittner

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

4 Citations (Scopus)


Alzheimer’s disease was first described in 1906 and since then tremendous efforts have been made to fully understand the disease pathology and to find a cure for this neurodegenerative disease. The diagnosis of Alzheimer’s is still difficult, especially in early stages of the disease. Current treatment of Alzheimer’s only ameliorates the symptoms but fails to provide a therapy. Over the last decades, animal models have been proven valuable in elucidating insights of the pathology. In vitro models using patient-derived cells are currently emerging and hold great promise in understanding the disease pathophysiology. Here, we introduce the neurobiology and genetic features of Alzheimer’s and describe what we have learned from studies employing mouse models and patient-derived induced pluripotent stem cells.

Original languageEnglish
Title of host publicationNeurodegenerative diseases
Subtitle of host publicationpathology, mechanisms, and potential therapeutic targets
EditorsPhilip Beart, Michael Robinson, Marcus Rattray, Nicholas J. Maragakis
Place of PublicationCham
PublisherSpringer, Springer Nature
Number of pages27
ISBN (Electronic)9783319571935
ISBN (Print)9783319571911
Publication statusPublished - 1 Jan 2017
Externally publishedYes

Publication series

NameAdvances in Neurobiology
ISSN (Print)2190-5215


  • Alzheimer’s disease
  • Amyloid-β
  • Excitotoxicity
  • Induced pluripotent stem cells
  • Mouse models
  • Tau


Dive into the research topics of 'Alzheimer’s disease: insights from genetic mouse models and current advances in human IPSC-derived neurons'. Together they form a unique fingerprint.

Cite this